logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12599616 B1

PDFFull Text
Date of Patent:
Apr. 14, 2026

Filed:

Feb. 26, 2021

Subtituted sulfonylurea and sulfoximineurea derivatives

Applicant:

Zydus Lifesciences Limited, Ahmedabad, IN;

Inventors:

Rajiv Sharma, Ahmedabad, IN;

Sameer Agarwal, Ahmedabad, IN;

Assignee:

ZYDUS LIFESCIENCES LIMITED, Gujarat, IN;

Attorney:

RENNER, KENNER, GREIVE, BOBAK, TAYLOR & WEBER CO. LPA

Primary Examiner:

Kamal A Saeed

Assistant Examiner:

Sagar undefined Patel

Int. Cl.
CPC ...
A61K 31/64 (2006.01); A61K 31/545 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01); A61P 29/00 (2006.01); C07C 311/55 (2006.01); C07C 381/10 (2006.01); C07D 211/58 (2006.01); C07D 295/084 (2006.01); C07D 295/088 (2006.01); C07D 295/13 (2006.01); C07D 309/14 (2006.01); C07D 335/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/64 (2013.01); A61K 31/545 (2013.01); A61K 38/20 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); C07C 311/55 (2013.01); C07C 381/10 (2013.01); C07D 211/58 (2013.01); C07D 295/084 (2013.01); C07D 295/13 (2013.01); C07D 309/14 (2013.01); C07D 335/02 (2013.01); C07C 2601/02 (2017.05); C07C 2601/04 (2017.05); C07C 2601/08 (2017.05); C07C 2601/14 (2017.05); C07C 2603/10 (2017.05);
Abstract

The present invention relates to novel compounds of the general formula (I) their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers and polymorphs. The invention also relates to processes for the preparation of the compounds of invention, pharmaceutical compositions containing the compounds and their use as the compounds of the invention belong to the family of NOD-like receptor family (NLR) protein NLRP3 modulators. The present invention thus relates to novel NLRP3 modulators as well as to the use of the novel inhibitor compounds in the treatment of diseases or conditions in which interleukin 1β activity is implicated.

Find Patent Forward Citations

Sharma, Rajiv. (2026). Subtituted sulfonylurea and sulfoximineurea derivatives (U.S. Patent No. 12599616). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12599616

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…